Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...

Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...

This narrative review examines evidence linking Attention-Deficit/Hyperactivity Disorder (ADHD) and long-term brain health, ...

A study evaluates disinfectants for decontaminating dropped implants in surgery, highlighting risks and the efficacy of CHG ...

The effects of dry-cured ham on cardiometabolic health are nuanced, with evidence suggesting it may not adversely affect key ...

Trial shows fewer HF hospitalizations in HFpEF ...

Clinically meaningful MG-ADL response (≥2-point reduction) occurred in 69% of treated patients, exceeding the 53% response ...

New human research reveals how gut bacteria and creatine may restore brain energy and improve depression. If you have or know ...

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.

Historically good results with IL-4 inhibitors raise questions with U.S. audience ...

Stakeholders responding to recent draft guidance from the US Food and Drug Administration (FDA) on the use of minimal ...